Kairos Pharma (KAPA) News Today $0.87 +0.01 (+1.64%) As of 04/25/2025 04:10 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesSEC FilingsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Kairos Pharma Ltd. Provides Letter to StockholdersApril 24 at 7:33 PM | finance.yahoo.comKairos Pharma (NYSEAMERICAN:KAPA) Given "Buy" Rating at D. Boral CapitalApril 19, 2025 | americanbankingnews.comQ1 EPS Estimates for Kairos Pharma Boosted by HC WainwrightApril 19, 2025 | americanbankingnews.comKairos Pharma Ltd. Announces Department of Defense Grant to Support Its Study of Lead Compound ENV105 to Prevent Drug Resistance in Lung CancerApril 17, 2025 | finance.yahoo.comKairos Pharma initiated with a Buy at H.C. WainwrightApril 3, 2025 | markets.businessinsider.comHC Wainwright & Co. Initiates Coverage of Kairos Pharma (KAPA) with Buy RecommendationApril 3, 2025 | msn.comKairos Pharma Ltd (KAPA)April 2, 2025 | investing.comKairos Pharma completes safety lead-in of ENV105 trialApril 1, 2025 | markets.businessinsider.comKairos Pharma Ltd. Announces Completed Enrollment of the Safety Arm of Its Phase 2 Clinical Trial of ENV105 in Metastatic, Castration-Resistant Prostate CancerMarch 31, 2025 | businesswire.comKairos Pharma initiated with a Buy at MaximMarch 28, 2025 | markets.businessinsider.comCEO.CA's Inside the Boardroom: Kairos Pharma's Breakthrough Cancer Treatment & What's Next for ENV105March 28, 2025 | finance.yahoo.comMaxim Group Initiates Coverage of Kairos Pharma (KAPA) with Buy RecommendationMarch 28, 2025 | msn.comKairos Pharma Ltd. Highlights Participation in Recent and Upcoming Scientific and Industry EventsMarch 27, 2025 | businesswire.comKairos Pharma Ltd. Announces Peer Reviewed Publication Highlighting Potentially Groundbreaking Discovery in Overcoming Drug Resistance in Non-Small Cell Lung CancerMarch 20, 2025 | businesswire.comKairos Pharma presents preclinical data on KROS 101, KROS 401February 26, 2025 | markets.businessinsider.comKairos Pharma Presents Preclinical Data on its Investigational Compounds KROS 101 and KROS 401 Further Supporting Both Compounds' Potential as Therapeutics for Melanoma and GlioblastomaFebruary 26, 2025 | businesswire.com Get Kairos Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for KAPA and its competitors with MarketBeat's FREE daily newsletter. Email Address KAPA Media Mentions By Week KAPA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KAPA News Sentiment▼0.561.03▲Average Medical News Sentiment KAPA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KAPA Articles This Week▼22▲KAPA Articles Average Week Get Kairos Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for KAPA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Quince Therapeutics News Today Century Therapeutics News Today Skye Bioscience News Today HST Global News Today Applied Therapeutics News Today Verrica Pharmaceuticals News Today Provectus Biopharmaceuticals News Today Xilio Therapeutics News Today Shattuck Labs News Today Spero Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:KAPA) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kairos Pharma, LTD. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kairos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KAPA Stock Free KAPA Stock Alerts